Dr. Matthew Levine, MD (he/him) is an Endocrinologist in La jolla, CA with over 16 years of experience. What is your opinion of Dr. Matthew Levine, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Matthew Levine, MD has received over $241,052 which includes payments from the following companies:
$75,580.07 from Novo Nordisk Inc
$62,701.10 from Janssen Pharmaceuticals, Inc
$29,206.24 from Boehringer Ingelheim Pharmaceuticals, Inc.
$24,299.64 from LILLY USA, LLC
$18,173.53 from AstraZeneca Pharmaceuticals LP
$10,093.93 from AbbVie, Inc.
$8,668.48 from Merck Sharp & Dohme Corporation
$4,277.41 from Amgen Inc.
$1,779.80 from sanofi-aventis U.S. LLC
$903.93 from INSULET CORPORATION
$540.37 from GlaxoSmithKline, LLC.
$440.18 from Medtronic MiniMed, Inc.
$440.04 from MannKind Corporation
$373.97 from Dexcom, Inc.
$359.02 from Valeritas, Inc.
$310.83 from Takeda Pharmaceuticals America, Inc.
$292.54 from Corcept Therapeutics
$291.38 from Tandem Diabetes Care, Inc.
$275.40 from Becton, Dickinson and Company
$244.22 from Abbott Laboratories
Payments received by Dr. Matthew Levine, MD were from the following categories:
$198,307.73 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!